BGPT: Author Review: M.L.

Explore by Goal

Low confidence. Please provide more context.

Low answer quality. Please provide more context.

Quick Explanation Copied

M.L. scientific profile (from provided metadata)

Bibliometrics: h-index 2, total citations 42, paper count 2.
Authorship list (provided): 3 paper titles are shown, but the metadata is inconsistent (paper count vs listed papers), so I treat the bibliometrics as the more reliable field.
Overall assessment: appears to have contributed to multiple experimental domains (e.g., diagnostics/antigens, antiviral evaluation, functional food), but there’s insufficient item-level full-text evidence here to judge rigor reproducibility, or mechanistic depth for M.L.’s specific work.

Long Explanation

BGPT Author Review: M.L.

Date: April 27, 2026

This review is constrained to explicitly provided information in your prompt: bibliometrics, an “M.L.” paper-title list, and an unrelated set of paper-level extraction objects. No full-text methods/results for M.L.’s specific papers were provided, so I cannot accurately score experimental rigor from primary evidence.

1) Citation metrics & publication footprint (as provided)

h-index	2
Total citations	42
Paper count	2
Affiliations listed	[] (none provided)

Important inconsistency flag: your prompt includes a “papers:” array with 3 paper titles while the stated “paper count” is 2. I therefore avoid treating either count as fully consistent with the title list.

2) Domains suggested by the provided paper titles (title-level only)

Provided M.L. paper titles

Cactus fruit jiotilla (Escontria chiotilla) — functional food from Mexico
Comparison of ELISA using recombinant LipL32 and sonicated antigen of leptospira — detecting bovine leptospirosis
Evaluation of free or liposome-encapsulated ribavirin — antiviral therapy of feline infectious peritonitis

What I can’t conclude: without abstract/full-text, I cannot determine experimental design quality, sample sizes, controls, statistics, or reproducibility details for M.L.’s specific contributions.

3) Evidence-strength critique (what’s known vs unknown)

Known from prompt

Bibliometrics: h-index 2; total citations 42; paper count 2 (as provided).
Title-level topic coverage spanning: (i) functional food; (ii) ELISA diagnostic assay comparison; (iii) antiviral evaluation with formulation (liposomes).

Unknown / cannot be inferred without full text

Whether the work is methodologically rigorous (controls, blinding, randomization, pre-registration, data availability).
Whether statistical inference supports the conclusions (effect sizes, confidence intervals, multiple testing handling).
Whether results are reproducible (independent replication, multi-lab validation, dataset/code deposition).
Whether the author is first/last/major contributor on each item.

4) Visual diagnostics from the provided paper-extraction objects (not attributed to M.L.)

The following figures summarize quality/risk-style metadata from your provided “RESEARCH DATA TO UTILIZE + GRAPH” list. These are not automatically linked to M.L.; I’m using them only to show how the prompt’s dataset is structured for scoring, and to highlight potential rigor/reproducibility dimensions.

Interpretation caution: some objects have missing/ND reproducibility fields in the extraction list, so zeros here reflect “not provided / not quantified in the extraction”, not necessarily low rigor.

5) Score rationale (based only on your provided metadata)

Scientific quality (score driver)

Bibliometrics suggest a small output footprint in the provided snapshot (paper count 2, h-index 2), which makes it hard to infer stable methodological expertise without full-text evidence.
Title-level topics indicate competence across biological/biomedical subareas, but this is not proof of experimental rigor or reproducibility.

Main red-flags / blind spots

Attribution ambiguity: the OpenAlex “top_author” result shown for “M.L.” appears to be a different person (“Matthew Meyerson”). I therefore do not treat that OpenAlex blob as confirming M.L.’s citation profile.
Missing item-level evidence: no full-text methods/results/stats for M.L.’s specific papers were supplied.
Dataset mismatch: the provided extraction objects for many DOIs are not explicitly linked to M.L.

What would change this assessment?

Full-text of M.L.’s ELISA/diagnostic and antiviral/formulation papers with sample sizes, controls, effect sizes, and data availability statements.
Clarification of authorship position (first/last/corresponding) for each cited item.
Clear mapping from the “M.L.” identifier to the exact author identity (to avoid h-index misattribution).

Feedback:

Updated: April 27, 2026